Form 4 holding
Director
IONIS PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 59,597
- Estimated value
- $3,004,702
- Report date
- 15 Jul 2022
- Price
- $50.42
- Ownership
- Direct
Frederick T. Muto
Insider Reports History
- Reporting-owner location
- Carlsbad, CA
- Latest reporting-owner signature
-
By: Patrick R. O'Neil, attorney-in-fact For: Frederick T. Muto
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Frederick T. Muto
Form 4 holding
Director
IONIS PHARMACEUTICALS INC
- Security class
- Restricted Stock Unit
- Shares / value
- 7,110
- Estimated value
- $358,465
- Report date
- 15 Jul 2022
- Price
- $50.42
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
IONIS PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 1,500
- Estimated value
- $75,626
- Report date
- 15 Jul 2022
- Price
- $50.42
- Ownership
- By Cooley Pen Plan
Form 4 holding
Director
IONIS PHARMACEUTICALS INC
- Security class
- Non-Qualified Stock Option (right to buy)
- Shares / value
- 12,000
- Estimated value
- Report date
- 01 Jul 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Frederick T. Muto
4
IONS
IONIS PHARMACEUTICALS INC
- Report period
- 15 Jul 2022
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 19 Jul 2022, 19:21
- Role
- Director
- Next action
- Open filing details
4
IONS
IONIS PHARMACEUTICALS INC
- Report period
- 01 Jul 2022
- Transactions
- 4
- Transaction value
- +$145,575
- Accepted by SEC
- 06 Jul 2022, 17:25
- Role
- Director
- Next action
- Open filing details
4
IONS
IONIS PHARMACEUTICALS INC
- Report period
- 15 Jul 2021
- Transactions
- 8
- Transaction value
- $0
- Accepted by SEC
- 19 Jul 2021, 20:15
- Role
- Director
- Next action
- Open filing details
4
IONS
IONIS PHARMACEUTICALS INC
- Report period
- 01 Jul 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 06 Jul 2021, 17:51
- Role
- Director
- Next action
- Open filing details
4
IONS
IONIS PHARMACEUTICALS INC
- Report period
- 15 Jun 2021
- Transactions
- 9
- Transaction value
- -$410,000
- Accepted by SEC
- 17 Jun 2021, 17:05
- Role
- Director
- Next action
- Open filing details